Fresenius Medical Care AG & Co. KGaA Extends FY2022 Net Income Target Range

0

EQS-Ad-hoc: Fresenius Medical Care AG & Co. KGaA / Key word(s): Forecast modification
Fresenius Medical Care AG & Co. KGaA Extends FY2022 Net Income Target Range

30-Oct-2022 / 17:30 CET/CEST
Disclosure of privileged information according to. in Article 17 MAR of Regulation (EU) No 596/2014, transmitted by EQS News – a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.


As Fresenius Medical Care continues to operate in a challenging environment, the impacts of the Company’s focused efforts to improve North American Healthcare Services operations are delayed from previous assumptions. Consequently, Fresenius Medical Care now assumes lower contributions for the 2022 financial year.

Consequently, Fresenius Medical Care now expects net profit (attributable to shareholders of Fresenius Medical Care AG & Co. KGaA) for the financial year 2022 to fall within the teen to mid-teen percentage range. around twenty. The Company continues to expect revenue growth in the single-digit percentage range in fiscal 2022. These targets are in constant currency and exclude special items.

Contact:

Dr Dominik Heger
EVP | Head of Investor Relations, Strategic Development and Communications
[email protected]
+49 6172 609 2601


October 30, 2022 CET/CEST EQS distribution services include regulatory announcements, financial/corporate news and press releases.
Archives on www.eqs-news.com


Language: English
Company: Fresenius Medical Care AG & Co. KGaA
Else-Kröner-Strasse 1
61352 Bad Homburg
Germany
Call: +49 (0) 6172- 609 2525
Fax: +49 (0) 6172- 609 2301
E-mail: [email protected]
The Internet: www.freseniusmedicalcare.com
IS IN: DE0005785802
WKN: 578580
Clues: DAX
Listed: Regulated Market in Frankfurt (Prime Standard); Unofficial regulated market in Berlin, Düsseldorf, Hamburg, Hanover, Munich, Stuttgart, Tradegate Exchange; NYSE, Luxembourg Stock Exchange
EQS News ID: 1475053

End of announcement EQS News Service

1475053 Oct 30, 2022 CET/CEST

Share.

Comments are closed.